v3.26.1
Statement of Changes in Shareholders’ Deficit - 7 months ended Dec. 31, 2025 - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 03, 2025
Balance (in Shares) at Jun. 03, 2025      
Class B ordinary shares issued to sponsor $ 1,380 23,619 24,999
Class B ordinary shares issued to sponsor (in Shares) 13,800,000 [1],[2]      
Sale of Private Placement Units $ 50 4,999,950 5,000,000
Sale of Private Placement Units (in Shares) 500,000        
Fair value of Public Warrants at issuance 2,028,600 2,028,600
Allocated value of transaction costs to Class A Ordinary Shares (103,589) (103,589)
Accretion of Class A Ordinary Shares subject to possible redemption to redemption amount (6,948,580) (14,594,663) 21,543,243
Net income 382,098 382,098
Balance at Dec. 31, 2025 $ 50 $ 1,380 $ (14,212,565) $ (14,211,135)
Balance (in Shares) at Dec. 31, 2025 500,000 13,800,000 [1],[2]      
[1] Excluded an aggregate of up to 1,800,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised. On December 18, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering, as such, the 1,800,000 Founder Shares are no longer subject to forfeiture (see Note 5).
[2] On June 4, 2025, the Company issued 8,625,000 Founder Shares to the Sponsor. In November 2025 and December 2025, the Company issued an additional 2,875,000 and 2,300,000 Founder Shares, respectively, to the Sponsor, resulting in a total of 13,800,000 Founder Shares (see Note 5).